Scott Kopetz

4 ta ish

Azienda Unita' Sanitaria Locale Di Modena

1. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

   Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong +17

   MaqolaOAOchiq kirish20183 iqtibos

   ABIABI:AkademIndex/2026.other.241935

2. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

   Michael J. Overman, Ray McDermott, Joseph L. Leach +13

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.241933

3. <i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

   Hui Ling, Riccardo Spizzo, Yaser Atlasi +50

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.472408

4. Cancer classification using the Immunoscore: a worldwide task force

   Jérôme Galon, Franck Pagès, Francesco M. Marincola +61

   Sharh maqola20122 iqtibos

   ABIABI:AkademIndex/2026.other.620112